Shares of Blend Labs, Inc. (NYSE:BLND - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven research firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $4.8833.
BLND has been the topic of several analyst reports. Wall Street Zen upgraded Blend Labs from a "sell" rating to a "hold" rating in a report on Sunday, August 17th. UBS Group decreased their price objective on Blend Labs from $4.00 to $3.50 and set a "neutral" rating on the stock in a report on Friday, August 8th. Canaccord Genuity Group restated a "buy" rating and set a $5.25 price objective on shares of Blend Labs in a report on Friday, August 22nd. Keefe, Bruyette & Woods reduced their target price on Blend Labs from $4.00 to $3.75 and set a "market perform" rating on the stock in a report on Friday, August 8th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $7.00 target price on shares of Blend Labs in a report on Wednesday, May 28th.
Get Our Latest Research Report on Blend Labs
Insider Activity
In other news, insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $2.87, for a total transaction of $71,750.00. Following the sale, the insider directly owned 696,598 shares of the company's stock, valued at approximately $1,999,236.26. The trade was a 3.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nima Ghamsari sold 311,886 shares of Blend Labs stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $2.90, for a total value of $904,469.40. Following the sale, the insider directly owned 5,754,051 shares in the company, valued at approximately $16,686,747.90. The trade was a 5.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 441,886 shares of company stock worth $1,334,169 over the last three months. 35.52% of the stock is currently owned by corporate insiders.
Institutional Trading of Blend Labs
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Acadian Asset Management LLC boosted its stake in Blend Labs by 36.0% in the first quarter. Acadian Asset Management LLC now owns 1,430,949 shares of the company's stock valued at $4,788,000 after acquiring an additional 378,667 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new position in Blend Labs in the first quarter valued at approximately $64,000. Rhumbline Advisers boosted its stake in Blend Labs by 10.9% in the first quarter. Rhumbline Advisers now owns 324,773 shares of the company's stock valued at $1,088,000 after acquiring an additional 32,030 shares during the period. Merit Financial Group LLC acquired a new position in Blend Labs in the first quarter valued at approximately $36,000. Finally, Pallas Capital Advisors LLC acquired a new position in Blend Labs in the first quarter valued at approximately $51,000. 52.56% of the stock is owned by institutional investors.
Blend Labs Stock Down 5.9%
Shares of BLND stock traded down $0.25 during mid-day trading on Tuesday, hitting $3.96. 5,737,634 shares of the company's stock were exchanged, compared to its average volume of 2,959,349. Blend Labs has a fifty-two week low of $2.63 and a fifty-two week high of $5.53. The stock has a 50-day simple moving average of $3.57 and a two-hundred day simple moving average of $3.46. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of -26.40 and a beta of 1.25.
Blend Labs (NYSE:BLND - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.05). The firm had revenue of $31.52 million during the quarter, compared to analyst estimates of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. As a group, analysts anticipate that Blend Labs will post -0.19 earnings per share for the current fiscal year.
Blend Labs Company Profile
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Read More

Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.